The company joins a group of degrader ADC (or DAC) developers that includes Bristol Myers Squibb and Pfizer.

Types of errors were analyzed on three levels: (1) the stage of the drug-use process in which the error occurred, (2) the reported type of drug therapy problem, and ...

Small interfering RNA (siRNA) drugs are a class of therapeutic agents that silence specific genes associated with inherited diseases. However, siRNA drugs have challenges because siRNAs often silence ...

Drug-related problems in HIV treatment are prevalent, affecting treatment effectiveness and safety, with 99.7% of patients experiencing at least one DRP. Treatment safety was the most frequent problem ...

On Friday, the fledgling field of psychedelic medicine suffered a major setback. The FDA declined to approve MDMA-assisted therapy for PTSD, instead asking the drugmaker Lykos Therapeutics to conduct ...